Reproductive Biomedicine Online, published by Elsevier, is a leading peer-reviewed journal that has established itself as a pivotal resource in the fields of Developmental Biology, Obstetrics and Gynecology, and Reproductive Medicine. With an impressive Impact Factor and a Q1 ranking in its respective disciplines as of 2023, this journal provides a platform for innovative research and comprehensive reviews that contribute to advancements in reproductive healthcare. The journal boasts rigorous Scopus rankings, placing it within the top tiers of its categories, which underscores its significance in shaping contemporary biomedical inquiry. Although not open access, it remains widely accessible through institutional subscriptions, making its wealth of knowledge available to researchers, clinicians, and students alike. Since its inception in 2000, Reproductive Biomedicine Online has been committed to fostering a deeper understanding of reproductive processes and biomedicine, ensuring that its content remains relevant and impactful in addressing challenges in reproductive health, thereby championing exceptional scientific discourse.

The International Journal of Reproductive Biomedicine, an esteemed publication by SHAHID SADOUGHI UNIVERSITY OF MEDICAL SCIENCES, serves as a pivotal platform in the fields of obstetrics and gynecology as well as reproductive medicine. Established in 2011 and transitioning to an open access model in 2015, this journal facilitates the dissemination of innovative research and critical findings to a global audience, particularly focusing on advancements in reproductive health and biomedicine. With an impact factor reflective of its commitment to high-quality scientific inquiry, the journal has achieved a notable ranking of Q3 in both its categories for 2023, contributing to its growing influence within the academic community. Researchers and professionals benefit from its broad scope, which encompasses a range of topics essential to reproductive health, thus fostering a rich exchange of knowledge. The journal's accessibility allows students and professionals alike to engage with the latest findings and contribute to ongoing discussions within this vital field of study.

The Journal of the Turkish-German Gynecological Association, published by GALENOS PUBL HOUSE, stands as a significant contribution to the field of obstetrics and gynecology, fostering a vital dialogue between Turkish and German medical communities since its establishment. This peer-reviewed, Open Access journal, which has been accessible since 2000, provides a platform for the dissemination of cutting-edge research, clinical practices, and reviews that are pivotal for advancing women's health. With a current impact factor correlation reflecting its status within the Q3 category in the obstetrics and gynecology domain, the journal is ranked #108 out of 209 in Scopus, placing it in the 48th percentile for its field. Covering a broad range of topics from innovative treatment methods to emerging technologies in gynecology, this journal is dedicated to enriching the academic landscape and providing healthcare professionals, researchers, and students with valuable insights and knowledge essential for improving patient outcomes. The journal’s headquarters in Turkey underscores its commitment to enriching local and international discourse in women's health.

The International Journal of Fertility & Sterility, published by ROYAN Institute, is a leading academic platform dedicated to advancing knowledge in the fields of obstetrics, gynecology, and reproductive medicine. With an ISSN of 2008-076X and an E-ISSN of 2008-0778, this Open Access journal has been making significant contributions to the scientific community since its inception in 2007. Based in Tehran, Iran, the journal showcases rigorous research and promotes interdisciplinary collaboration, addressing critical topics related to fertility, sterility, and reproductive health. As of 2023, it holds an impressive Q2 ranking in Obstetrics and Gynecology and a Q3 ranking in Reproductive Medicine, underscoring its relevance and impact in the academic sphere, with Scopus ranks placing it at #67 in Obstetrics and Gynecology and #32 in Reproductive Medicine. The journal's commitment to accessibility and quality is reflected in its global readership, making it an essential resource for researchers, healthcare professionals, and students seeking to enhance their understanding of fertility issues and reproductive technologies.

HUMAN REPRODUCTION is a prestigious academic journal published by Oxford University Press, dedicated to advancing the field of reproductive medicine. With an impressive impact factor highlighting its significance, the journal ranks in the top quartile (Q1) for Obstetrics and Gynecology, Rehabilitation, and Reproductive Medicine, showcasing its crucial role in disseminating high-quality research. Founded in 1986, it has become a key resource for researchers, practitioners, and students interested in cutting-edge developments and innovative practices in human reproduction. Despite not currently offering open access, the journal continues to publish a wealth of peer-reviewed articles that contribute substantially to clinical knowledge and practice. With Scopus rankings placing it among the top journals in its categories, HUMAN REPRODUCTION remains an essential platform for discussion and dissemination of vital findings impacting reproductive health globally.

Reproductive Medicine and Biology, an esteemed journal published by WILEY, stands at the forefront of advancements in the field of reproductive health and associated biological sciences. With an impact factor that underscores its relevance—ranking in Q1 for Reproductive Medicine and Q3 in Cell Biology—this journal is distinguished by its commitment to disseminating high-quality, peer-reviewed research since its transition to Open Access in 2002. Based in Japan, the journal caters to a global audience, providing vital insights into reproductive biology, therapeutics, and innovative practices. With Scopus rankings placing it at #22 out of 90 in Reproductive Medicine and a commendable percentile ranking, Reproductive Medicine and Biology aims to foster dialogue and knowledge transfer among researchers, professionals, and students, paving the way for breakthroughs in understanding reproductive health.

Fertility and Sterility is a prestigious peer-reviewed journal dedicated to the fields of obstetrics, gynecology, and reproductive medicine. Published by Elsevier Science Inc, this journal has been a cornerstone of scientific discourse since its inception in 1950 and is set to continue its influential coverage of cutting-edge research until 2024. Boasting an impressive impact factor, Fertility and Sterility is ranked among the top-tier journals in its category, holding Q1 status in both Obstetrics and Gynecology and Reproductive Medicine. With Scopus rankings placing it in the 97th and 96th percentiles respectively, the publication serves as a vital resource for researchers, clinicians, and students who seek to advance their understanding of fertility issues and reproductive health. Although it does not currently offer open access options, the journal remains committed to disseminating high-quality research and innovative solutions to the complex challenges in reproduction, empowering professionals and scholars to make meaningful contributions in their fields.

The JOURNAL OF REPRODUCTIVE IMMUNOLOGY, published by Elsevier Ireland Ltd, stands as a pivotal platform for exploring the intricate interactions between reproductive health and the immune system. With an ISSN of 0165-0378 and an E-ISSN of 1872-7603, this esteemed journal spans over four decades, from 1979 to 2024, contributing significantly to the fields of Immunology, Reproductive Medicine, and Obstetrics and Gynecology. Currently ranked in Q2 for Immunology and Allergy and Q1 for both Obstetrics and Gynecology and Reproductive Medicine, it serves as an invaluable resource for researchers, professionals, and students dedicated to advancing knowledge in reproductive health. The journal’s notable impact factor and rigorous peer-review process underscore its commitment to high-quality research, making it an essential reference point for ongoing studies in this ever-evolving discipline. By promoting interdisciplinary discussions and pioneering research findings, the JOURNAL OF REPRODUCTIVE IMMUNOLOGY fosters a deeper understanding of the immune mechanisms that influence reproductive outcomes.

JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH, published by Wiley, is a leading journal in the field of obstetrics and gynecology that has been disseminating high-quality research since its inception. With an ISSN of 1341-8076 and an E-ISSN of 1447-0756, this journal thrives on contributing to this specialized area of medicine, showcasing innovations and advancements essential for practitioners and scholars alike. Notably, it holds a commendable Impact Factor reflective of its Q2 ranking in both Medicine and Obstetrics and Gynecology categories for 2023, placing it in the 55th percentile among its peers according to Scopus. The journal covers a wide array of topics pertinent to contemporary medical practices and research in Australia and beyond, aiming to foster interdisciplinary dialogue and advance clinical practices. Researchers, professionals, and students will find it an invaluable resource, featuring rigorous peer-reviewed articles that shed light on emerging trends, clinical guidelines, and groundbreaking studies. As it continues to converge on pivotal medical issues up until 2024, JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH stands poised to make a lasting impact in the realm of women's health.

GEBURTSHILFE UND FRAUENHEILKUNDE is a prestigious journal dedicated to the fields of Maternity, Midwifery, Obstetrics, and Gynecology, published by GEORG THIEME VERLAG KG, a reputable publisher known for its commitment to advancing medical knowledge. Established in 1947, the journal has consistently provided a platform for high-quality research and clinical studies that address current challenges and innovations in women's health. With an impact factor positioned in Q2 for Maternity and Midwifery and Q3 in Obstetrics and Gynecology, it ranks among the top journals within its field, further solidified by its Scopus rankings highlighting its influential presence. Although the journal is not open access, it remains an essential resource for academics and practitioners keen to stay informed on the latest evidence-based practices and cutting-edge research, ensuring that all stakeholders in women's healthcare can access critical insights to enhance patient outcomes.